ChinaBio Today -- Guizhou Baiqiang Pharmaceutical Co. Ltd. has held a groundbreaking for a new manufacturing facility that will increase capacity to produce its anti-tumor drug, a combination of disodium cantharidinate and vitamin B6 injection. The company says the drug has a synergistic effect when used with other cancer medications, reduces the side-effects of chemotherapy and improves liver function. It is approved to treat advanced lung cancer.
